Health TrialsbyHealthPanel

Mobile Technology to Reduce Teen Substance Misuse

ConditionsSubstance UseSubstance AbuseSuicideAdolescent
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13+
SponsorEvidence-Based Practice Institute, Seattle, WA

About this trial

The goal of this study is to test the newly expanded WisePath for Teens (WPT) for substance use app, a direct-to-consumer paired mobile phone app for iOS and Android platforms that supports parents/guardians in delivering evidence-based techniques to reduce youth substance abuse and co-occurring mental health problems. This project will expand WPT for use with a general population of teens with problematic substance use and their parents to reduce substance abuse, its harmful effects, opioid overdoses, and progression to substance use disorders, as well as other behavioral health problems that are exacerbated by substance abuse and/or interfere with substance abuse treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Resides in United States

13-17 years of age

Fluent in English

Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis

Disqualifiers

Participated in previous iKinnect or WisePath for Teens research in the past 2 years

Participated in previous iKinnect or WisePath for Teens research in the past 2 years

Currently involved with the child protective service system due to a concern about child maltreatment (i.e., abuse or neglect).

Trial design

Design model

Parallel

Treatments tested in this trial

  • WisePath for Teens

    Other intervention

    WPT is a paired mobile phone app for use on both Android and iOS operating systems by youth experiencing SA and their parents/guardians.

  • Peer Support Services (PSS)

    Behavioral

    PSS are provided by people with lived experience with histories of adolescent substance abuse and are now in recovery who are also certified as peer support specialists. A specialist will virtually (e.g., over the phone, screensharing) meet with families regularly to provide support and ensure that families are able to use iKinnect-SA and access the app's features.

  • Control

    Device

    Website with icon on participant's phone with Android or iOS operating systems.

Treatment groups

600 Participants
are divided into 3 treatment groups
Group A: WPTExperimental treatment 1 intervention
Group B: WPT + PSSExperimental treatment 2 interventions
Group C: WILLOWActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Timeline Followback Method Assessment (TLFB)

The TLFB assesses use of alcohol and 13 different drugs over the past 30 days. It involves asking clients to retrospectively estimate their drug, marijuana or cigarette use.

Time frame
Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)
2

Change in Global Assessment of Individual Needs-Q3 (GAIN)

Scales from GAIN specifically identify and address substance use frequency (3 items), substance problems (5 items), crime/violence (5 items), and recovery environment risk (9 items) and are well-validated for adolescents.

Time frame
Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)
3

Change in Achenbach (Child/Adult) Behavior Checklist

A widely used 123-item caregiver report form used to assess youth behavioral and emotional problems.

Time frame
Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)
4

Change in Family Environment Scale (FES)

A widely-used measure of family conflict (12 items) and cohesion (15 items).

Time frame
Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

Secondary outcomes

Other outcomes

1

Demographics Questionnaire

Self-report measure to collect demographics from participants in this study. Questions include items about gender, race, and ethnicity.

Time frame
Eligibility Screening
2

Screening to Brief Intervention (S2BI) scale

8-item scale assessing the frequency and severity of use with 90% and 94% sensitivity to detect moderate to severe SA, respectively.

Time frame
Eligibility Screening

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Evidence-Based Practice Institute, Seattle, WA

Lead sponsor

University of Maryland, Baltimore

Collaborator

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov
Apply now